Statin-Naïve Paraneoplastic Anti-HMGCR Myopathy / 대한신경근육질환학회지
Korean Journal of Neuromuscular Disorders
; (2): 15-19, 2021.
Artículo
en Coreano
| WPRIM (Pacífico Occidental)
| ID: wpr-902280
Biblioteca responsable:
WPRO
ABSTRACT
Anti-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (anti-HMGCR) myopathy is a subtype of immune-mediated necrotizing myopathy regardless of exposure to statins. Necrotizing myopathy is distinguished by necrotic muscle fibers with a relative lack of inflammation. It is frequently associated with a high risk of permanent muscle damage and disability. Recent studies have suggested a slightly increased risk of cancer in patients with anti-HMGCR myopathy. This report describes a case of statin-naïve paraneoplastic anti-HMGCR myopathy, with rapidly progressive muscle weakness leading to respiratory failure.
Texto completo:
Disponible
Base de datos:
WPRIM (Pacífico Occidental)
Idioma:
Coreano
Revista:
Korean Journal of Neuromuscular Disorders
Año:
2021
Tipo del documento:
Artículo